Verona Pharma plc CEO David Zaccardelli's 2021 pay falls 94% to $1.1M
Verona Pharma plc reports 2021 executive compensation
By ExecPay News
Published: March 21, 2023
Verona Pharma plc reported fiscal year 2021 executive compensation information on March 21, 2023.
In 2021, four executives at Verona Pharma plc received on average a compensation package of $791K, a 93% decrease compared to previous year.
Average pay of disclosed executives at Verona Pharma plc
David Zaccardelli, Chief Executive Officer, received $1.1M in total, which decreased by 94% compared to 2020. 44% of Zaccardelli's compensation, or $496K, was in stock awards. Zaccardelli also received $328K in non-equity incentive plan, $273K in salary, as well as $26K in other compensation.
Mark W. Hahn, Chief Financial Officer, received a compensation package of $738K. 55% of the compensation package, or $403K, was in salary.
Mark Hahn, Chief Financial Officer, earned $738K in 2021, a 96% decrease compared to previous year.
Kathleen Rickard, Chief Medical Officer, received $562K in 2021, which decreases by 86% compared to 2020.
Related executives
You may also like
Source: SEC filing on March 21, 2023.